Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAXIVA axitinib study in clear cell renal cell carcinoma with venous tumour thrombus
ISRCTN96273644Phase 2Completed
- Sponsor
- NHS National Services Scotland
- Start
- Dec 2017
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of axitinib in clear cell renal cell carcinoma (ccRCC), sponsored by NHS National Services Scotland. Primary endpoint: Change in thrombus invasion by Mayo classification. Started Dec 2017; status: completed.
02
Drugs
axitinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on ISRCTN96273644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96273644.